Home | Subscribe To The Final Call | Books & Tapes e-Store| Letters/Contact Us | TV & Radio  

Last Updated: May 21st, 2008 

Front Page 
 
  Minister Louis Farrakhan
 
  National News
 
  World News
 
  Perspectives
 
  Columns
 
  Business & Money
 
  Entertainment News
 
  Health & Fitness
 
  Modern Technology
 
  Features
 
  Finalcall.com Español




Subscribe to FCN E-List

Enter email address:

Email Delivery Format:
HTML  Plain Text
Manage Your Subscription


The Unmasking
of New Orleans

The Untold Story
of Hurricane Katrina



Exclusive Webcast:
The Havana Cuba
Press Conference

FCN, March 27, 2006

 



Business with disease: The scourge of prescription drugs
By Sultan Muhammad
Updated Jan 26, 2004, 11:30 am

What's your opinion on this article?

Email this article
 Printable page

(FinalCall.com) - According to a genetics expert from the largest European pharmaceutical corporation in the world, GlaxoSmithKline, 90 percent of drugs only work in 30-50 percent of people. Geneticist Allen Roses said that "drugs in the market work, but they don’t work in everybody."

Mr. Roses also quoted research results by a medical diagnostic, Brian Spear, who three years earlier, had found that different drugs had vastly different success rates in treating patients.

The consequences of this finding are real and form the basis of what is termed "business with disease" in an astounding complaint filed with the International Criminal Court that names President George Bush, members of  his staff, British Prime Minister Tony Blair and some of the largest pharmaceutical companies in the world, including GlaxoSmithKline.

However, this information seldom reaches the patients who are prescribed these drugs. Whether they work or not, these drugs are paid for by the patient or government programs that supplement the cost.

Just recently, President Bush signed a $400 billion healthcare bill which, according to Congresswoman Nancy Pelosi, will set aside $139 billion for drug companies. Despite questions on their effectiveness, the pharmaceutical companies get paid.

The medical term describing the adverse effects of drugs administered by doctors is "iatrogenetics." In fact, any adverse condition resulting from the care of a physician or surgeon, especially in cases of infections acquired by the patient during the course of treatment, is termed "iatrogenetic."

"It is evident that the American medical system is the leading cause of death and injury in the United States," declared a medical group that released a study entitled, "Death by Medicine."

The researchers of the study examined different aspects of iatrogenic occurrences and styled tables and charts to show the devastating horrors not reported. They found that as many as 7.5 million unnecessary medical and surgical procedures are performed annually, and that 8.9 million patients may have been exposed to hospitalization unnecessarily.

Three independent studies of iatrogneic deaths concluded that 106,000 deaths resulted from adverse drug reactions; 98,000 deaths were caused by medical errors; and more than 115,000 cases of bedsores ended in death. The economic cost of medical intervention in these cases totaled almost $70 billion.

These figures, the study continued, represent only a one-year period. However, if these stats were to be multiplied by 10 years, the total number of iatrogenic deaths would exceed all the casualties of the wars in which America has fought. The projected figure is approximately 7.8 million iatrogenic deaths.

"What we must deduce from this report is that medicine is in need of complete and total reform. We are fully aware that what stands in the way of change are powerful pharmaceutical companies, medical technology companies and special interest groups with enormous vested interests in the business of medicine," the study acknowledged. 

The anthrax vaccine was initially pushed by President George Bush Sr., during his presidency, for the military. Now, under his son’s presidency, an anthrax scare pervades as the vaccine is urged for the public.

Bioport, the lone manufacturer of the anthrax vaccine, has as one of its major investors, the Carlyle Investment Group—one of the key supporters of both Bush campaigns. The family is also a member of the Carlyle Investment Group.

Avemtis Corporation is a major manufacturer of the now popular "flu vaccine" that the public is now rushing to get for fear of a dreaded "killer" flu virus. Aventis profits can be traced back to supporters of the Bush presidency. Secretary of Defense Donald Rumsfeld was, at one time, the head of Searle Pharmaceuticals. 

"You only have to look at the number of invested people on hospital, medical and government health advisory boards to see the conflict of interest," the report continued.

Recently, U.S. District Court Judge Emmet Sullivan ruled that the military could not force soldiers to take the anthrax vaccine, equating such force as treating the troops like "guinea pigs."


 


FCN is a distributor (and not a publisher) of content supplied by third parties. Original content supplied by FCN and FinalCall.com News is Copyright © 2008 FCN Publishing, FinalCall.com. Content supplied by third parties are the property of their respective owners.

Top of Page

National News
Latest Headlines
Educational Conference focuses on solutions
U.S. Army says suicide; Parents seek investigation
The census is coming
After apology, will America repent?
Farrakhan: New educational solutions needed
Realtors to confront mortgage meltdown
Policy change gives LAPD chief more power
Respect My Vote goes after out-of-college youth
Urban League head pushes voter registration
Will stiff sentences stop body parts sales?
Media controversy highlights rift in Jewish community
Black journalists offer different view of Africa
Police checkpoints return to D.C. neighborhood
Muslims condemn Post’s 'Jihad Train' smear
Taser death ruled a homicide, family wants justice